Skip to search.
 BSE Up 0.12% NSE Up 0.15%
Streaming
Ticker Tape: On

More On TRABI.BO

Quotes

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transgene Biotek Ltd. (TRABI.BO)

-BSE

2.04 Up 0.09(4.62%) 19 Jun 3:20PM

Add to Portfolio
Prev Close:1.95
Open:2.04
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1.99 - 2.04
52wk Range:1.71 - 25.80
Volume:2,967,065
Avg Vol (3m):215,556
Market Cap:134.17M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in INR.

Headlines

  • No Headlines available for TRABI.BO at this time.

Comparison

Symbol% ChgMkt Cap
TRABI.BOUp 4.62%134.17M
PFZ.L 0.00%173.71B
GSK.LDown 0.66%80.65B
AZN.LDown 0.29%40.51B
JNJ.MXDown 0.34%3.11T
» More Competitors

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.85
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transgene Biotek Limited engages in the development of bio generic drugs, drug delivery systems, and pharmaceutical products in India. The company’s bio generic products comprise Orlistat, a lipase inhibitor used for obesity management; Tacro... View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback